Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Middeldorp

Showing results (91-100 of 123) with videos related to

Pageof 13
Sort By:
Annals of Internal Medicine|September 1, 2001
A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolismS Middeldorp, J R Meinardi, M M Koopman, et al.
Thrombosis and Haemostasis|August 6, 2000
Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptivesJ C Meijers, S Middeldorp, W Tekelenburg, et al.
Trials|January 19, 2022
Tranexamic acid to prevent operation in chronic subdural haematoma (TORCH): study protocol for a randomised placebo-controlled clinical trialS Immenga, R Lodewijkx, Y B W E M Roos, et al.
Scientific Reports|January 23, 2020
Platelet transfusion in patients with aneurysmal subarachnoid hemorrhage is associated with poor clinical outcomeR Post, M A Tjerkstra, S Middeldorp, et al.
Thrombosis Research|September 25, 2020
Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patientsRomein W G Dujardin, Bashar N Hilderink, Wolmet E Haksteen, et al.
Journal of Thrombosis and Haemostasis : JTH|December 9, 2010
Prevalence of JAK2V617F mutation in women with unexplained recurrent miscarriageS P Kaandorp, M N Lauw, C E van der Schoot, et al.
Thrombosis and Haemostasis|August 6, 2000
Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over studyS Middeldorp, J C Meijers, A E van den Ende, et al.
The Cochrane Database of Systematic Reviews|July 20, 2007
Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulationE A Akl, F F van Doormaal, M Barba, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphismN Abdelmalik, H G Ruhé, K Barwari, et al.
Lancet (London, England)|January 15, 2000
Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over studyJ Rosing, S Middeldorp, J Curvers, et al.
Pageof 13

Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Annals of Internal Medicine|September 1, 2001
A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolismS Middeldorp, J R Meinardi, M M Koopman, et al.
Thrombosis and Haemostasis|August 6, 2000
Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptivesJ C Meijers, S Middeldorp, W Tekelenburg, et al.
Trials|January 19, 2022
Tranexamic acid to prevent operation in chronic subdural haematoma (TORCH): study protocol for a randomised placebo-controlled clinical trialS Immenga, R Lodewijkx, Y B W E M Roos, et al.
Scientific Reports|January 23, 2020
Platelet transfusion in patients with aneurysmal subarachnoid hemorrhage is associated with poor clinical outcomeR Post, M A Tjerkstra, S Middeldorp, et al.
Thrombosis Research|September 25, 2020
Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patientsRomein W G Dujardin, Bashar N Hilderink, Wolmet E Haksteen, et al.
Journal of Thrombosis and Haemostasis : JTH|December 9, 2010
Prevalence of JAK2V617F mutation in women with unexplained recurrent miscarriageS P Kaandorp, M N Lauw, C E van der Schoot, et al.
Thrombosis and Haemostasis|August 6, 2000
Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over studyS Middeldorp, J C Meijers, A E van den Ende, et al.
The Cochrane Database of Systematic Reviews|July 20, 2007
Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulationE A Akl, F F van Doormaal, M Barba, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphismN Abdelmalik, H G Ruhé, K Barwari, et al.
Lancet (London, England)|January 15, 2000
Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over studyJ Rosing, S Middeldorp, J Curvers, et al.
Pageof 13